Company profile for Genentech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medic...
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1 DNA Way, South San Francisco, CA 94080
Telephone
Telephone
+1-650-225-1000, +1 (800) 626-3553
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251117114377/en/Genentechs-Giredestrant-Becomes-the-First-Oral-SERD-to-Show-Superior-Invasive-Disease-Free-Survival-in-Early-Breast-Cancer

BUSINESSWIRE
18 Nov 2025

https://www.businesswire.com/news/home/20251109262712/en/Genentechs-Fenebrutinib-Shows-Unprecedented-Positive-Phase-III-Results-as-the-Potential-First-and-Only-BTK-Inhibitor-in-Both-Relapsing-and-Primary-Progressive-Multiple-Sclerosis

BUSINESSWIRE
09 Nov 2025

https://www.businesswire.com/news/home/20251103924016/en/Genentech-to-Present-New-Data-From-Its-Broad-and-Innovative-Hematology-Portfolio-at-ASH-2025

BUSINESSWIRE
03 Nov 2025

https://www.businesswire.com/news/home/20251102365331/en/Positive-Phase-III-Data-for-Genentechs-Gazyva-Show-Significant-Reduction-in-Disease-Activity-for-Systemic-Lupus-Erythematosus

BUSINESSWIRE
03 Nov 2025

https://www.fiercebiotech.com/biotech/genentech-says-goodbye-118-employees-third-hq-layoff-round-year

FIERCE BIOTECH
29 Oct 2025

https://www.businesswire.com/news/home/20251020110977/en/Ventus-Therapeutics-Enters-into-a-Collaboration-and-License-Agreement-with-Genentech-to-Discover-and-Develop-Small-Molecule-Medicines-Using-Ventus-ReSOLVE-Platform

BUSINESSWIRE
21 Oct 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Genentech and get a quotation

Genentech is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find a price of CED88004A bulk offered by Genentech

Find a price of TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN G bulk offered by Genentech

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SOUTH SAN FRANCISCO. bulk offered by Genentech

Find a price of DORNASE ALFA INHALATION SOLUTION (GENENTECH) bulk offered by Genentech

Find a price of CED88004S bulk offered by Genentech

Find a price of THROMBOPOIETIN (HUMAN, RECOMBINANT, CHO CELLS, GENENTECH) bulk offered by Genentech

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty